Clinical trial
Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II…
NCT00424203 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00424203 |
|---|---|
| Title | Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery |
| Official title | Multicenter Pilot Clinical Study of Adjuvant Chemotherapy for Subjects Over 70 Years: Impact on the Independence and Quality of Life of the Administration of Anthracycline-Based Chemotherapy in Adjuvant Setting for Patients Presenting With Immediately Operable Breast Cancer, Hormone Receptor… |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Cognitive/Functional Effects, Depression, Malnutrition, Psychosocial Effects of Cancer and Its Treatment |
| Intervention type | Drug, Procedure |
| Interventions | AC regimen, cyclophosphamide, doxorubicin hydrochloride, adjuvant therapy, cognitive assessment, management of therapy complications, psychosocial assessment and care, quality-of-life assessment |
| Enrollment | 40 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Nov 1, 2011 |
| First posted | Jan 18, 2007 |
| Last update posted | Sep 4, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: